These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Listed as ongoing, but also has a completion date and reported results 2004-000023-15 A Comparison of CS-747 and Clopidogrel in Acute Coronary Syndrome Subjects who are to Undergo Percutaneous Coronary Intervention 2007-07-22 bad-data
Reported results 2004-000028-34 A randomised Phase 3 Trial of ALIMTA and Cisplatin versus GEMZAR and Cisplatin in Patients with locally advanced or metastatic Non-Small-Cell Lung Cancer 2008-03-10 due-trials
Reported results 2004-000167-95 Duloxetine versus Placebo in the Prevention of Recurrence in Major Depressive Disorder 2008-01-23 due-trials
Not reported 2004-000349-40 Efficacy of Exenatide Compared with Insulin Glargine in Patients with Type 2 Diabetes Using Metformin or Sulfonylurea for Whom Insulin is the Next Appropriate Therapy 2005-10-18 due-trials
Listed as ongoing, but also has a completion date 2004-000573-54 An open label study examining the long term safety of exenatide given twice daily to patients with type 2 diabetes mellitus. 2009-04-07 bad-data
Ongoing 2004-000577-65 A Phase 3, randomized, open label, comparator-controlled, parallel-group, multicentre study to compare the effects of exenatide and insulin glargine on beta cell function and cardiovascular risk marke... not-yet-due
Completed, but no date, and reported results 2004-000580-10 Effect of Tadalafil on the Quality of Life and Sexual Life Satisfaction in Erectile Dysfunction (ED) Patients Previously Treated with other Oral ED therapy bad-data
Ongoing, reported early 2004-000589-11 Protocol F1D-MC-HGKR. Olanzapine Plus Carbamazepine Versus Carbamazepine Alone in the Treatment of Manic or Mixed Episodes Associated with Bipolar I Disorder not-yet-due
Ongoing, reported early 2004-000691-13 A phase 2 study of ALIMTA plus doxorubicin administered every 21 days in patients with advanced breast cancer not-yet-due
Listed as ongoing, but also has a completion date 2004-000815-25 A randomized phase 3 study of two doses of ALIMTA in patients with locally advanced or metastatic Non-Small Cell Lung Cancer who have failed a prior platinum-containing chemotherapy. 2006-12-31 bad-data
Completed, but no date, and reported results 2004-000894-67 The Effect of Teriparatide on Distal Radius Fracture Healing bad-data
Listed as ongoing, but also has a completion date and reported results 2004-000986-37 An Open-Label Study of Intramuscular Olanzapine Depot in Patients With Schizophrenia or Schizoaffective Disorder 2010-12-31 bad-data
Completed, but no date, and reported results 2004-001033-41 A Randomized, Double-Blind, Parallel-Design, Placebo-Controlled Study to Evluate the Efficacy and Safety of Tadalafil (2.5 mg e 5 mg) administered once daily to men with diabetes mellitus and erectile... bad-data
Ongoing, reported early 2004-001237-42 Open-Label Duloxetine Extension phase in Patients Who Have Completed the F1J-MC-HMDG Clinical Trial Fase de extensión abierta con duloxetina en aquellos pacientes que hayan finalizado el ensayo clíni... not-yet-due
Ongoing 2004-001308-11 Optimal Treatment Duration with Olanzapine following Remission of Manic or Mixed Episode. An Open-Label, Randomized Trial Comparing Two Treatment Strategies not-yet-due
Ongoing, reported early 2004-001319-71 A Phase IIIb Study to Determine Efficacy and Safety of Extended Drotrecogin Alfa (Activated) Therapy in Patients With Persistent Requirement for Vasopressor Support After 96-Hour Infusion With Commerc... not-yet-due
Reported results 2004-001482-17 Olanzapine Versus Divalproex and Placebo in the Treatment of Mild to Moderate Mania Associated with Bipolar I disorder. 2006-12-13 due-trials
Ongoing, reported early 2004-001562-41 Efectos del Arzoxifeno en la incidencia de fracturas vertebrales y en la incidencia de cáncer de mama invasivo en las mujeres posmenopáusicas con osteoporosis o con baja densidad ósea not-yet-due
Reported results 2004-002425-52 A Phase 3 Study of Pemetrexed Plus Best Supportive Care versus Best Supportive Care As Maintenance Therapy Immediately Following Induction Treatment For Advanced Non-Small Cell Lung Cancer 2013-12-03 due-trials
Completed, but no date, and reported results 2004-002537-39 Phase II Trial of Neoadjuvant ALIMTA plus Cisplatin followed by Surgery and Radiation in the Treatment of Pleural Mesothelioma bad-data
Reported results 2004-002626-22 Duloxetine 60 to 120 mg Once Daily Compared with Placebo in the Prevention of Relapse in Generalized Anxiety Disorder 2007-03-14 due-trials
Completed, reported early 2004-002782-20 A Phase 1 and 2 Clinical Trial of ALIMTA (Pemetrexed) in Combination with Carboplatin in Patients with Recurrent Ovarian or Primary Peritoneal Cancer 2010-02-23 not-yet-due
Listed as ongoing, but also has a completion date and reported results 2004-002784-24 A Randomized, Double-Blind, Phase 2 Study of Two Doses of Pemetrexed in the Treatment of Platinum-Resistant, Epithelial Ovarian or Primary Peritoneal Cancer 2007-03-06 bad-data
Not reported 2004-003941-42 A Randomised, Double Blind Placebo Controlled Study of the Broader Efficacy of Atomoxetine Hydrochloride in the Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in Swedish Children and Ado... 2006-08-21 due-trials
Ongoing, reported early 2004-004088-31 A Randomized Double-Blind, Placebo-Controlled Clinical Trial of Efficacy and Safety of Atomoxetine up to 12 weeks in Newly Diagnosed Children and Adolescents Outpatients with Attention-Deficit/Hypera... not-yet-due
Ongoing, reported early 2004-004149-16 Phase 1/2 Study of Biweekly ALIMTA plus Cisplatin in patients with Locally Advanced, non-Resectable or Metastatic Urothelial Cancer not-yet-due
Listed as ongoing, but also has a completion date 2004-004160-67 Effect of Duloxetine on Valsalva Leak Point Pressure and Quantitative Rhabdosphincter Electromyography Measures in Women with Stress Urinary Incontinence 2006-03-21 bad-data
Ongoing, reported early 2004-004960-64 A Comparison of Duloxetine Hydrochloride, Venlafaxine Extended Release, and Placebo in the Treatment of Generalized Anxiety Disorder not-yet-due
Reported results 2004-005068-26 A Phase 2 Study of Oral Enzastaurin HCl in Patients with Metastatic Colorectal Cancer 2008-03-06 due-trials
Listed as ongoing, but also has a completion date and reported results 2005-000021-32 A Randomized Phase 2 Trial of Doxorubicin plus Pemetrexed followed by Docetaxel, versus Doxorubicin plus Cyclophosphamide followed by Docetaxel, as Neoadjuvant Treatment for Early Breast Cancer 2011-03-17 bad-data
Not reported 2005-000515-95 Differential Effects of Teriparatide and Strontium Ranelate on Bone Remodeling and Formation in Postmenopausal Women with Osteoporosis: A Histomorphometric Study 2006-01-24 due-trials
Reported results 2005-000566-40 A Pivotal Long-Term, Open-Label, Parallel Study of the Efficacy and Safety of Human Insulin Inhalation Powder in Patients with Type 1 Diabetes Mellitus 2008-05-28 due-trials
Listed as ongoing, but also has a completion date and reported results 2005-000900-15 The effect of Ruboxistaurin on Clinically Significant Macular Edema in Patients with Diabetes Mellitus, as assessed by Optical Coherence Tomography 2011-07-14 bad-data
Listed as ongoing, but also has a completion date and reported results 2005-001524-37 Duloxetine 60/120 mg Versus Placebo in the Treatment of Fibromyalgia Syndrome 2007-06-27 bad-data
Completed, but no date, and reported results 2005-001527-11 A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma bad-data
Completed, but no date, and reported results 2005-001545-42 A Randomized Phase III Trial of Gemcitabine and Docetaxel versus Gemcitabine and Paclitaxel in Patients with Metastatic Breast Cancer: a comparison of different schedules bad-data
Completed, but no date, and reported results 2005-001750-25 Efficacy and Safety of Somatropin in Combination with Leuprorelin Compared to Somatropin Alone and to an Untreated Control Group in Pubertal Children with Idiopathic Short Stature bad-data
Ongoing, reported early 2005-002115-24 Complaints Associated with Use of the Prefilled Pen B When Used by Patients with Type 2 Diabetes on Twice-Daily Insulin Therapy not-yet-due
Ongoing 2005-002174-30 The Use of Nuclear Scintigraphy to Evaluate the Anabolic Effects of Teriparatide on the Skeleton in Postmenopausal Women in Osteoporosis not-yet-due
Ongoing, reported early 2005-002279-33 Tratamiento con Alimta (Pemetrexed) y cisplatino como tratamiento neoadyuvante en el cancer no microcitico de pulmon not-yet-due
Ongoing 2005-002430-34 Efectos del bloqueo 5HT2A en pacientes deprimidos con respuesta inadecuada al tratamiento antidepresivo not-yet-due
Listed as ongoing, but also has a completion date 2005-002660-29 A Phase 1b/2 Multiple-Dose Safety and Pharmacokinetic/Pharmacodynamic Study of LY2189102 in Patients with Rheumatoid Arthritis 2007-11-19 bad-data
Listed as ongoing, but also has a completion date and reported results 2005-002692-33 A randomized, Double blind, Placebo controlled phase 3 Study of the phosphodiesterae Type 5 PDE Inhibiotr Tadalafil in the Treatment of patients with Pulomanry Arterial Hypertension. 2008-08-16 bad-data
Listed as ongoing, but also has a completion date and reported results 2005-002844-24 A Double-Blind, Extension Study to Evaluate the Long-Term Safety and Efficacy of the Phosphodiesterase Type 5 (PDE5) Inhibitor Tadalafil in the Treatment of Patients with Pulmonary Arterial Hypertensi... 2012-02-27 bad-data
Reported results 2005-002911-26 A Randomized Phase 2 Study of Pemetrexed in Combination with Cisplatin or Carboplatin as Adjuvant Chemotherapy in Patients with Completely Resected Stage Ib or II Non-Small Cell Lung Cancer 2013-07-30 due-trials
Completed, reported early 2005-003718-14 Estudio fase I/II de quimioterapia con la combinación de Pemetrexed y Cisplatino concomitante con radioterapia seguida de quimioterapia de consolidación con Pemetrexed en pacientes con cáncer de pulmó... 2010-08-06 not-yet-due
Ongoing, reported early 2005-004157-99 A Randomized, Open-Label Study Comparing the Effects of Olanzapine Pamoate Depot with Oral Olanzapine on Treatment Outcomes in Outpatients with Schizophrenia not-yet-due
Not reported 2005-004188-50 Maintenance of effect of Duloxetine 60 mg Once Daily in patients with Diabetic Peripheral Neuropathic Pain. 2007-10-30 due-trials
Listed as ongoing, but also has a completion date 2005-004627-18 A Randomized Phase 3 Study of Enzastaurin versus Lomustine in the Treatment of Recurrent, Intracranial Glioblastoma Multiforme 2014-08-19 bad-data
Listed as ongoing, but also has a completion date and reported results 2005-004630-41 A Phase 3 Clinical Study to Investigate the Prevention of Relapse in Lymphoma Using Daily Enzastaurin 2013-07-31 bad-data
Reported results 2005-004747-64 A Phase 3, Open-Label, Parallel Group Study to Evaluate the Efficacy and Safety of Human Insulin Inhalation Powder (HIIP) Compared to Preprandial Injectable Insulin in Insulin-Naïve Patients with Type... 2008-06-03 due-trials
Listed as ongoing, but also has a completion date and reported results 2005-004963-42 Estudio DURABLE: Evaluación de la DURAbilidad de la eficacia de insulina Basal frente a insulina Lispro de baja mEzclaDurabilidad de la insulina lispro de baja mezcla (insulina lispro LM) administrada... 2010-01-25 bad-data
Not reported 2005-004966-17 PPAR Alpha (LY518674): a Phase 2 Dose-Response Study to Evaluate the Blood Pressure-Lowering Effect in Essential Hypertension 2006-09-29 due-trials
Other 2005-005219-36 A Phase 2 Single-Arm Study of Gemcitabine in Combination with Oxaliplatin in Pediatric Patients with Relapsed or Refractory Neuroblastoma or Miscellaneous Solid Non-CNS Tumors not-yet-due
Reported results 2005-005258-29 “Estudio para evaluar el efecto de Teriparatida comparado con Risedronato en el dolor de espalda de las mujeres postmenopausicas con fracturas vertebrales osteoporóticas” 2010-06-23 due-trials
Reported results 2005-005292-15 A Pharmacokinetic and Pharmacodynamic Comparison of Prasugrel (LY640315) versus Clopidogrel in Subjects with Stable Atherosclerosis 2006-12-06 due-trials
Reported results 2005-005381-37 A Phase 3, Open-Label, Parallel Group Treatment Concordance Study to Compare Insulin Use and Its Effect on Glycemic Control in Patients with Type 2 Diabetes Mellitus: Two Populations with Different I... 2008-01-05 due-trials
Listed as ongoing, but also has a completion date 2005-005448-21 Long-Term Treatment with Exenatide versus Glimepiride in Patients with Type 2 Diabetes Pretreated with Metformin 2011-03-30 bad-data
Listed as ongoing, but also has a completion date and reported results 2005-005535-10 A Phase 2 study of ALIMTA in solid tumor patients with stable third-space fluid 2009-03-20 bad-data
Completed, but no date, and reported results 2005-005701-32 An Open-Label Study of the Efficacy of Atomoxetine Hydrochloride on Quality of Life of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder with or without comorbid conditions bad-data
Reported results 2005-005929-62 A Feasibility study of Pemetrexed single agent and folic acid given as neoadjuvant treatment in patients with resectable rectal cancer 2009-06-05 due-trials
Ongoing 2005-006164-59 An Open Label Study Comparing Exenatide with Basal Insulin in Achieving an HbA1c of <_7.4% with Minimum Weight Gain, in Type 2 Diabetes Patients who are not Achieving Adequate HbA1c Control on Oral An... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2006-000247-26 A Phase 3, Open-Label, Three-Group Parallel Study to Evaluate the Efficacy and Safety of Human Insulin Inhalation Powder (HIIP) in Patients with Type 2 Diabetes Treated with Once-Daily Insulin Glargin... 2008-05-30 bad-data
Reported results 2006-000441-19 A randomised Phase II study of two chemotherapy regimens, Pemetrexed-Carboplatin, and Gemcitabine-vinorelbine, in Anthracycline and Taxane pretreated Advanced Breast cancer patients. 2010-08-27 due-trials
Reported results 2006-000497-80 A Phase 3, Open-Label, Parallel Group Study to Evaluate the Efficacy of Preprandial Human Insulin Inhalation Powder HIIP Compared to Preprandial Injectable Insulin in Patients with Type 1 Diabetes M... 2008-05-27 due-trials
Listed as ongoing, but also has a completion date and reported results 2006-000813-39 Prasugrel in comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation (PRINCIPLE) - TIMI 44 2007-06-20 bad-data
Reported results 2006-000889-36 A Double-blind, Randomized, Placebo-controlled Multicentre Phase II Study of Maintenance Enzastaurin Following Whole Brain Radiation Therapy in the Treatment of Brain Metastases from Lung Cancer 2011-02-01 due-trials
Listed as ongoing, but also has a completion date and reported results 2006-001173-14 A Randomised Phase 3 Trial of Alimta (pemetrexed) and Carboplatin versus Etoposide and Carboplatin in Extensive-Stage Small Cell Lung Cancer. 2008-06-06 bad-data
Completed, but no date 2006-001470-25 Randomisierte, doppelblinde Studie zum Vergleich neuropsychologischer Effekte von Atomoxetin gegen Placebo im Tagesverlauf bei Kindern mit Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung unter Anwendun... bad-data
Reported results 2006-001471-37 A Randomized, Double-Blind Comparison of Atomoxetine versus Placebo in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder and Comorbid Oppositional Defiant Disorder 2009-01-23 due-trials
Completed, but no date 2006-001721-26 The Genetics and Neuroendocrinology of Short Stature International Study (GeNeSIS) bad-data
Completed, but no date, and reported results 2006-001836-32 Pemetrexed monochemotherapy in patients with locally advanced or metastatic Non Small Cell Lung Cancer. A pilot study to define the best dosing schedule for a planned phase II randomized trial. bad-data
Completed, but no date 2006-001938-41 Effect of Exenatide plus Metformin vs. Premixed Human Insulin Aspart plus Metformin on Glycemic Control and Hypoglycemia in Patients with Inadequate Control of Type 2 Diabetes on Oral Antidiabetic Tre... bad-data
Listed as ongoing, but also has a completion date and reported results 2006-001958-27 A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, 5-Group, Multinational Study to Evaluate the Efficacy, Dose Response, and Safety of Tadalafil Once-a-Day Dosing for 12 Weeks in Men ... 2009-05-14 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-001985-17 An Open-label, Single Arm, Phase 2 Study of Rituximab, Gemcitabine, and Oxaliplatin plus Oral Enzastaurin as Treatment for Patients with Relapsed Diffuse Large B-Cell Lymphoma 2012-11-05 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-001987-22 “Comparación de la Eficacia y Seguridad de Arzoxifeno frente a Raloxifeno en mujeres posmenopáusicas con Osteoporosis” 2008-07-01 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-002112-99 A Phase 2 Study to Evaluate Dose and Duration of Treatment of Drotrecogin Alfa (Activated) Using Serial Measurements of Protein C in Patients with Severe Sepsis and Multiple Organ Dysfunction 2009-09-30 bad-data
Reported results 2006-002316-10 A Randomized, Phase 2, Placebo-Controlled, Double-Blinded Study With and Without Enzastaurin in Combination With Paclitaxel and Carboplatin as First-Line Treatment, Followed by Maintenance Treatment i... 2012-07-11 due-trials
Reported results 2006-002321-23 A Phase 2 Study of LY573636 Administered a san Intravenous Infusion on Day 1 of a 21-Day cycle as third-line Treatment in patients with unresectable, metastatic non-Small Cell lung cancer 2008-10-13 due-trials
Ongoing 2006-002519-28 Ensayo PRIME DT2: Regímenes prandiales-basales de Insulina para mejorar la glucemia post-pandrial en Diabetes Tipo 2.Comparación de dos enfoques con terapia basal y en bolo en pacientes con Diabetes t... not-yet-due
Ongoing, reported early 2006-002618-37 A Randomized, Double-Blind, Cross-Over Study Comparing the Pharmacodynamic Response in Subjects with Acute Coronary Syndrome Receiving 14 Days 10-mg Maintenance Dose Prasugrel (LY640315) versus 14 Day... not-yet-due
Reported results 2006-002818-35 A Randomized Phase 2 Study of Pemetrexed in Combination with Cisplatin or Carboplatin in the First Line Therapy of Advanced NSCLC 2009-04-20 due-trials
Listed as ongoing, but also has a completion date 2006-002893-23 An Open Label Single Arm Phase 1b/2 Study with Pharmacokinetic Sampling to Evaluate LY2181308 in Patients with Advanced Hepatocellular Carcinoma 2008-08-08 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-002922-51 Tadalafil 5 mg Once a Day Compared to Placebo in Improving Erectile Dysfunction and Sexual Quality of Life 2008-01-03 bad-data
Reported results 2006-002999-17 A Phase 3, Open-Label, Parallel-Group Study to Compare Two Dosing Algorithms for Preprandial Human Insulin Inhalation Powder (HIIP) in Insulin-Naïve Patients with Type 2 Diabetes Mellitus 2008-05-14 due-trials
Ongoing, reported early 2006-003007-39 Phase I/II Study of Concurrent Cisplatin, Pemetrexed, and Radiotherapy for Limited Stage Small Cell Lung Cancer not-yet-due
Ongoing 2006-003076-35 Treatment Strategies in Patients with Type 2 Diabetes Mellitus Not Achieving Glycemic Control while on Therapy with Premixed Insulin Analogues and Metformin: A Comparison of Insulin Lispro MM Intensi... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2006-003158-12 A Randomized Phase 3 Study of Pemetrexed in Combination with Cisplatin Versus Cisplatin Monotherapy in Patients with Recurrent or Metastatic Head and Neck Cancer 2010-03-17 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-003484-31 Effect of Duloxetine 60 mg to 120 mg Once Daily in Patients with Chronic Low Back Pain 2008-10-17 bad-data
Ongoing, reported early 2006-003485-33 Duloxetine 60 to 120 mg versus Placebo in the Treatment of Patients with Osteoarthritis Knee Pain not-yet-due
Reported results 2006-004486-34 An Open-Label Study of Oral Enzastaurin HCI in Patients with Advanced or Metastatic Malignancies 2009-07-29 due-trials
Reported results 2006-005118-11 A phase 2 study of Pemetrexed versus Pemetrexed + Erlotinib in second line Treatment for NSCLC 2010-10-14 due-trials
Ongoing 2006-005305-58 A Randomized, Double-Blind, Phase 2 Trial of Fulvestrant Plus Enzastaurin versus Fulvestrant Plus Placebo in Aromatase Inhibitor-Resistant Metastatic Breast Cancer not-yet-due
Reported results 2006-005306-31 Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Gemcitabine and Cisplatin Plus Enzastaurin versus Gemcitabine and Cisplatin Plus Placebo, Followed by Maintenance Enzastaurin or Placebo ... 2008-08-25 due-trials
No trial status on register 2006-005346-37 A Randomized, Double-Blind, Placebo-Controlled Maintenance of Effect Study of Olanzapine in the Treatment of Disruptive Behavioral Symptoms in Children and Adolescents with Pervasive Developmental Dis... bad-data
Ongoing, reported early 2006-005383-51 A Phase 3, Open-Label, Crossover Study to Evaluate the Efficacy and Safety of Human Insulin Inhalation Powder (HIIP) Compared with Once-Daily Insulin Glargine in Insulin-Naïve Patients with Type 2 Dia... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2006-005512-27 A Randomized, Controlled, Open-Label Study of the Long-Term Impact on Functioning using Atomoxetine Hydrochloride Compared to Other Early Standard Care in the Treatment of Attention-Deficit/Hyperactiv... 2009-07-03 bad-data
Completed, but no date, and reported results 2006-005971-17 A Phase 2 Study of LY573636 as Treatment for Patients with Platinum-Resistant Ovarian Cancer Protocol H8K-MC-JZAG bad-data
Completed, but no date 2006-006043-32 An open label pilot study on the tolerability of duloxetine in the treatment of depressed patients with Parkinson s disease bad-data
Not reported 2006-006149-15 An Exploratory Study of the Effect of Treatment Interruption on Safety of Exenatide in Patients with Type 2 Diabetes 2008-04-29 due-trials
Reported results 2006-006315-68 “Comparación de los efectos de teriparatida frente a risedronato en la densidad mineral ósea volumétrica de la columna lumbar en varones con osteoporosis inducida por glucocorticoides” 2010-10-06 due-trials
Listed as ongoing, but also has a completion date and reported results 2006-006375-21 The COMPLETE T1D Trial: COMParison of Insulin Lispro Protamine Suspension and DETEmir in Type 1 Diabetes Comparison of Two Basal Insulin Analogs (Insulin Lispro Protamine Suspension and Insulin Detemi... 2008-08-18 bad-data
Ongoing, reported early 2006-006429-24 Ensayo Fase II de Pemetrexed más Cisplatino como tratamiento de pacientes con cáncer microcítico de pulmón, enfermedad extendida not-yet-due
Listed as ongoing, but also has a completion date and reported results 2006-006698-25 A Phase 2 Double-Blind Randomized Study of Oral Enzastaurin HCl versus Placebo Concurrently with Pemetrexed (Alimta) as Second-Line Therapy in Patients with Advanced or Metastatic Non-Small Cell L... 2008-08-18 bad-data
Reported results 2007-000281-21 Enzastaurin (LY317615) Before and Concomitant with Radiation Therapy, Followed by Enzastaurin Maintenance Therapy in Patients with Newly Diagnosed Glioblastoma without Methylation of the Promoter Gene... 2016-03-24 due-trials
Not reported 2007-000469-39 An Open Label Follow-up Study of Patients Who Participated in Clinical Study B9R-HL-GDDV. A Phase IV, one-arm follow-up study to assess final adult results of GH treatment in patients with the Prader... 2007-09-21 due-trials
Not reported 2007-000800-34 A Multi-center, Inpatient, Phase 2, Double-blind, Placebo-controlled Dose Ranging Study of LY2140023 in Patients with DSM-IV Schizophrenia. 2008-10-06 due-trials
Listed as ongoing, but also has a completion date and reported results 2007-000912-97 Phase II Trial of Pemetrexed in Second Line Advanced/Metastatic Osteosarcomas 2010-07-21 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-000913-13 Phase 2 Study of Concurrent Carboplatin, Pemetrexed, and Radiotherapy for Limited Stage Small Cell Lung Cancer 2008-10-18 bad-data
Ongoing, reported early 2007-001402-24 Estudio fase II de LY573636 sódico administrado como tratamiento de segunda o tercera línea en pacientes con sarcoma de tejido blando irresecable o metastásico not-yet-due
Reported results 2007-002150-39 Estudio COMPLETE DT2: COMParación de una suspensión de insulina Lispro protamina y DETEmir en Diabetes mellitus Tipo 2 Comparación de dos análogos de insulina basal (suspensión de insulina Lispro pro... 2008-09-26 due-trials
Listed as ongoing, but also has a completion date and reported results 2007-002418-20 Estudio PERSISTENT: Estudio prospectivo y aleatorizado en el que se compara la suspensión de insulina lispro con protamina con la insulina glargina en pacientes con diabetes tipo 2 que reciben medicac... 2008-10-02 bad-data
Completed, but no date 2007-002691-33 A Study to Assess the Effect of Exenatide Treatment on Mean 24-hour Heart Rate in Patients with Type 2 Diabetes bad-data
Listed as ongoing, but also has a completion date 2007-002957-22 Efficacy of once weekly exenatide long acting release and once daily insulin glargine in patients with Type 2 diabetes treated with metformin alone or in combination with sulphonylurea. 2012-01-30 bad-data
Listed as ongoing, but also has a completion date 2007-003342-15 A Randomized, Open-Label Study Comparing the Effectiveness of Olanzapine Pamoate Depot with Haloperidol Decanoate in the Treatment of Schizophrenia 2008-06-13 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-003844-31 “A Double-Blind, Randomized, Phase 2 Study of Enzastaurin with 5-FU/Leucovorin plus Bevacizumab as Maintainence Regimen Following First-Line Therapy for Metastatic Colorectal Cancer” 2010-05-18 bad-data
Ongoing 2007-003847-66 Dose Finding and Randomized, Multicenter, Placebo- Controlled, Phase 2 Study of Enzastaurin and Sunitinib versus Placebo and Sunitinib in Patients with Metastatic Renal Cell Carcinoma not-yet-due
Ongoing, reported early 2007-003912-72 A Randomized Phase 2 Study Comparing Erlotinib-Pemetrexed, Pemetrexed alone, and Erlotinib alone, as Second-Line Treatment for Non-Smoker Patients with Locally Advanced or Metastatic Non-Small Cell Lu... not-yet-due
Ongoing 2007-004321-15 A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multicenter Study to Evaluate the Urodynamic Effects of Tadalafil Once a Day for 12 Weeks in Men With Signs and Symptoms of Benign Pros... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2007-004864-29 A Prospective Randomized Trial to Compare Basal Bolus therapies that use either Insulin Lispro Protamine Suspension or Insulin Glargine together with Lispro Insulin in Patients with Type 2 Diabetes 2010-02-25 bad-data
Reported results 2007-004907-37 A randomized phase 2 study of LY2181308 in combination with docetaxel versus docetaxel in hormone refractory prostate cancer 2012-04-02 due-trials
Reported results 2007-004950-10 Pemetrexed con suplemento simplificado de folato y dexametasona frente a pemetrexed con suplemento estándar como segunda línea de quimioterapia en pacientes con cáncer de pulmón no microcítico 2010-06-22 due-trials
Listed as ongoing, but also has a completion date and reported results 2007-005061-36 Comparación de un régimen de insulina lispro premezclada (proporción baja, 25/75; y proporción media, 50/50) con un régimen de inyecciones separadas de insulina basal y en bolos, en pacientes con diab... 2010-11-10 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-005118-37 Efecto de la inhibición de la γ-Secretasa sobre la progresión de la enfermedad de Alzheimer: LY450139 frente a placebo / Effect of γ-Secretase Inhibition on the Progression of Alzheimer’s Disease:... 2011-04-12 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-005210-39 A Comparison of Prasugrel and Clopidogrel in Acute Coronary Syndrome (ACS) Subjects with Unstable Angina/Non-ST-Elevation Myocardial Infarction (UA/NSTEMI) Who are Medically Managed - The TRILOGY ACS ... 2012-03-30 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-005441-38 Efficacy and Safety of Drotrecogin Alfa (Activated) in Adult Patients with Septic Shock 2012-02-29 bad-data
Not reported 2007-006246-17 A Phase 2 Study of Enzastaurin in Patients with Follicular Lymphoma 2014-12-17 due-trials
Listed as ongoing, but also has a completion date and reported results 2007-007198-21 A Phase 2/3, Placebo-Controlled, Efficacy and Safety Study of Once-Weekly, Subcutaneous LY2189265 Compared to Sitagliptin in Patients with Type 2 Diabetes Mellitus on Metformin 2012-07-06 bad-data
Listed as ongoing, but also has a completion date and reported results 2007-007672-41 Maintenance of Response After Open-Label Treatment with Atomoxetine Hydrochloride in Adult Outpatients with Attention-Deficit/Hyperactivity Disorder (ADHD): A Placebo-Controlled, Randomized Withdra... 2013-10-02 bad-data
Completed, but no date 2008-000191-24 An Open Label Pilot Study of Atomoxetine Hydrochloride in Adolescents with Attentioin-Deficit/Hyperactivity Disorder and Comorbid Cannabis Abuse bad-data
Ongoing, reported early 2008-000748-14 An Open Label, Multicenter Phase 2 Study of Single-Agent Enzastaurin HCl in Previously Treated Waldenstrom’s Macroglobulinemia or Multiple Myeloma not-yet-due
Listed as ongoing, but also has a completion date 2008-000854-11 Safety and Efficacy of Exenatide Once Weekly Injection versus Metformin, Dipeptidyl Peptidase-4 Inhibitor, or Thiazolidinedione as Monotherapy in Drug-Naive Patients with Type 2 Diabetes 2010-06-09 bad-data
Listed as ongoing, but also has a completion date and reported results 2008-001055-21 A Comparison of Psychosocial Outcomes following Tadalafil Once a Day or PDE5 Inhibitor As Needed in Men with Erectile Dysfunction 2009-09-21 bad-data
Listed as ongoing, but also has a completion date and reported results 2008-001105-42 A Phase 2 Study of Multiple Intravenous Doses of LY2127399, an Anti-BAFF Human Antibody, in Patients with Rheumatoid Arthritis on Concomitant Methotrexate and an Inadequate Response to TNFα Inhibitor ... 2010-05-27 bad-data
Listed as ongoing, but also has a completion date and reported results 2008-001170-32 estudio “Estudio fase III en el que se compara Pemetrexed, Cisplatino y radioterapia, seguido de tratamiento deconsolidación con Pemetrexed, frente a Etopósido, Cisplatino y radioterapia, seguido de t... 2014-11-06 bad-data
Completed, but no date 2008-001372-75 Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LY2245461 after Multiple Oral Administrations in Healthy Postmenopausal Women bad-data
Ongoing 2008-001535-35 A Phase 1b/2 Study of Gemcitabine-Cisplatin, With or Without LY2275796 Sodium, in Patients with Advanced Stage IIIB or IV Non-Small Cell Lung Cancer not-yet-due
Listed as ongoing, but also has a completion date 2008-001767-11 A Randomized, Controlled, Open-Label Comparison Study of the Efficacy and Safety of Slow Transitioning compared with Fast Transitioning from a Stimulant Medication to Atomoxetine in Pediatric and Adol... 2010-10-14 bad-data
Ongoing 2008-001829-33 Duloxetine Versus Placebo in the Long-Term Treatment of Patients with Late-Life Major Depression not-yet-due
Listed as ongoing, but also has a completion date 2008-002155-24 A Phase 3, Double-Blind, Placebo-Controlled Study of Maintenance Pemetrexed plus Best Supportive Care versus Best Supportive Care Immediately Following Induction Treatment with Pemetrexed + Cisplatin ... 2017-11-22 bad-data
Listed as ongoing, but also has a completion date and reported results 2008-002248-40 Efecto de Duloxetina 60 mg, Administrado una Vez al Día, Frente a Placebo, en Pacientes con Lumbalgia Crónica 2009-07-06 bad-data
Listed as ongoing, but also has a completion date and reported results 2008-002319-42 Comparación de dos estrategias de tratamiento diferentes en pacientes con trastorno depresivo mayor en tratamiento con escitalopram que no presentan mejoría: Estrategia de intervención temprana versus... 2010-05-03 bad-data
Completed, but no date 2008-002560-34 A Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy and Safety of Duloxetine HCl in Patients with Central Neuropathic Pain Due to Multiple Sclerosis bad-data
Listed as ongoing, but also has a completion date and reported results 2008-002693-35 Comparison of the Effects of Teriparatide with those of Risedronate on Lumbar Spine Bone Mineral Density in Men and Postmenopausal Women with Low Bone Mass and a Recent Pertrochanteric Hip Fracture 2015-10-20 bad-data
Listed as ongoing, but also has a completion date and reported results 2008-002758-39 Effect of LY450139, a g-Secretase Inhibitor, on the Progression of Alzheimer’s Disease as Compared with Placebo. 2011-07-11 bad-data
Reported results 2008-002841-21 A Phase 3, Randomized, Double Blind, Placebo Controlled, Parallel Design, Multinational Study to Evaluate the Efficacy and Safety of Daily Tadalafil for 12 Weeks in Men with Signs and Symptoms of Beni... 2009-11-09 due-trials
Reported results 2008-002857-18 A Randomized, Double-Blind Comparison of LY2216684 and Placebo and Long Term Treatment with LY2216684 in Adult Patients with Major Depressive Disorder 2011-03-02 due-trials
Not reported 2008-003843-36 A Randomized Trial Comparing Exenatide with Placebo in Subjects with Type 2 Diabetes on Insulin Glargine With or Without Oral Antihyperglycemic Medications 2010-01-04 due-trials
Listed as ongoing, but also has a completion date and reported results 2008-004207-63 A 12-Week, Double-Blind, Placebo-Controlled Trial of LY2428757 in Patients with Type 2 Diabetes Mellitus 2010-01-11 bad-data
Listed as ongoing, but also has a completion date and reported results 2008-004222-17 A Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Assess the Efficacy and Safety of Tadalafil (LY450190) once a Day in Subjects with Erectile Dysfuncion Who are Naive to PDE5 Inhibitor... 2010-01-15 bad-data
Listed as ongoing, but also has a completion date and reported results 2008-004330-24 A Phase 2 Study of Pemetrexed and Cisplatin plus Cetuximab followed by Pemetrexed and Cetuximab Maintenance Therapy in Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer (Stage II... 2014-11-19 bad-data
Listed as ongoing, but also has a completion date and reported results 2008-004337-25 A Randomized, Double-Blind, Placebo-Controlled, Parallel Design, Multinational Study to Evaluate the Efficacy and Safety of Tadalafil 2.5 and 5 mg Once Daily Dosing for 12 Weeks for the Treatment of E... 2010-10-14 bad-data
Reported results 2008-004451-30 A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study with and without Enzastaurin in Combination with Docetaxel and Prednisone, Followed by Enzastaurin Maintenance as First-Line Treatment in... 2010-06-03 due-trials
Listed as ongoing, but also has a completion date and reported results 2008-004875-23 An Open-Label Extension Study of Multiple Subcutaneous Doses of LY2127399, an Anti-BAFF Human Antibody, in Patients with Rheumatoid Arthritis 2012-01-13 bad-data
Ongoing, reported early 2008-004894-16 Phase 2, Dose-Ranging Study of Multiple Subcutaneous Doses of LY2127399, an Anti-BAFF Human Antibody, in Patients with Active Rheumatoid Arthritis Despite Ongoing Methotrexate Therapy not-yet-due
Reported results 2008-004997-41 Effectiveness of Prasugrel versus Clopidogrel in Subjects with High Platelet Reactivity on Clopidogrel Following Elective Percutaneous Coronary Intervention with Implantation of Drug-Eluting Stent 2011-03-18 due-trials
Ongoing, reported early 2008-005128-10 Assessment of Dose-Dependent Effects of LY2189265 on Glycemic Control in Patients with Type 2 Diabetes Treated only with Lifestyle Interventions not-yet-due
Completed, but no date 2008-005496-10 An Open-label, Randomized, Phase 2 Study of R-CHOP Plus Enzastaurin versus R-CHOP in the First-Line Treatment of Patients with Intermediate and High-Risk Diffuse Large B-Cell Lymphoma bad-data
Ongoing 2008-005695-27 Comparing Problem Solving Treatment combined with duloxetine with Problem Solving Treatment alone for patients with major depressive disorder in primary care not-yet-due
Reported results 2008-006209-17 A Phase 1/Randomized Phase 2 Study to Evaluate LY2603618 in Combination with Gemcitabine in Patients with Pancreatic Cancer 2013-12-09 due-trials
Listed as ongoing, but also has a completion date 2008-006317-25 A Comparison of Adding Exenatide with Switching to Exenatide in Patients with Type 2 Diabetes Experiencing Inadequate Glycemic Control with Sitagliptin plus Metformin 2010-04-12 bad-data
Listed as ongoing, but also has a completion date and reported results 2008-006492-71 A double-blind, efficacy and safety study of duloxetine versus placebo in the treatment of children and adolescents with major depressive disorder 2011-10-13 bad-data
Reported results 2008-006709-18 An exploratory, prospective phase II study to investigate progression-free survival, response and overall survival seen with pemetrexed/cisplatin and the role of thymidylate synthase expression. 2011-06-10 due-trials
Listed as ongoing, but also has a completion date and reported results 2008-006732-35 A Single-Arm, Phase 2 Trial of Pemetrexed, Cisplatin, and Bevacizumab as Induction, Followed by Pemetrexed and Bevacizumab as Maintenance, in First-Line Treatment of Nonsquamous Advanced, Non Small Ce... 2013-12-06 bad-data
Reported results 2008-007307-91 A Long-Term, Phase 2, Multicenter, Randomized, Open-Label, Comparative Safety Study of LY2140023 Versus Atypical Antipsychotic Standard of Care in Patients with DSM-IV-TR Schizophrenia 2010-12-21 due-trials
Listed as ongoing, but also has a completion date and reported results 2008-007459-28 Multiple Subcutaneous Doses of LY2127399, an Anti-BAFF Human Antibody, in Subjects with Relapsing-Remitting Multiple Sclerosis 2012-06-13 bad-data
Not reported 2008-007769-21 A Randomized, Open-label Study on the Effects of Insulin Pen Devices on Glycemic Control in Children, Adolescents and Adults with Type 1 Diabetes: Novel Pen with Memory Function (HumaPen® Memoir) vs. ... 2011-07-14 due-trials
Listed as ongoing, but also has a completion date 2008-007926-21 Effect of Passive Immunization on the Progression of Alzheimer`s Disease: LY2062430 versus Placebo 2012-08-20 bad-data
Listed as ongoing, but also has a completion date 2009-009500-39 A Randomized Trial Comparing either Basal Insulin/Glargine, Exenatide and Metformin Therapy (BET) or Basal Insulin/Glargine, Bolus Insulin Lispro and Metformin Therapy (BBT) in Subjects with Type 2 D... 2012-08-20 bad-data
Completed, but no date, and reported results 2009-009696-34 A Phase 2 Dose-Ranging Study of Multiple Subcutaneous Doses of LY2439821 (an Anti-IL-17 Antibody) in Patients with Active Rheumatoid Arthritis on Concomitant DMARD Therapy bad-data
Listed as ongoing, but also has a completion date and reported results 2009-010008-27 Duloxetine 60 mg once daily versus Placebo in the Treatment of Patients with Osteoarthritis Knee Pain 2010-05-20 bad-data
Listed as ongoing, but also has a completion date and reported results 2009-010063-16 Use of Duloxetine or Pregabalin in Monotherapy versus Combination Therapy of Both Drugs in Patients with Painful Diabetic Neuropathy The COMBO (COmbination vs Monotherapy of pregaBalin and dulOxetine... 2011-11-11 bad-data
Ongoing 2009-010188-18 Effectiveness of Transmural Collaborative care and Duloxetine for major depressive disorder and (sub)chronic pain: a randomized placebo-controlled Multi-Centre trial. not-yet-due
Reported results 2009-010276-16 A Long-Term, Open-Label, Safety Study of Oral Olanzapine in Adolescents with Bipolar I Disorder (Manic or Mixed Episodes) or Schizophrenia 2013-05-07 due-trials
Listed as ongoing, but also has a completion date and reported results 2009-010739-42 A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Global Multicenter Study to Evaluate the Efficacy and Safety of Tadalafil Once Daily Dosing for 12 Weeks in Men with Signs and... 2011-01-27 bad-data
Listed as ongoing, but also has a completion date 2009-010830-23 Efficacy of Once-Weekly Exenatide versus Once or Twice Daily Insulin Detemir in Patients with Type 2 Diabetes Treated with Metformin Alone or in Combination with Sulphonylurea 2011-12-29 bad-data
Listed as ongoing, but also has a completion date and reported results 2009-010902-13 Duloxetina versus placebo en el tratamiento de pacientes de avanzada edad con trastorno de ansiedad generalizada 2012-07-21 bad-data
Listed as ongoing, but also has a completion date and reported results 2009-011318-22 Efectos de la administración de tadalafilo (LY450190) una vez al día o a demanda en comparación con la administración de citrato de sildenafilo a demanda sobre la discontinuación del tratamiento en pa... 2011-06-15 bad-data
Ongoing, reported early 2009-011426-33 Assessing the Effect of Missing Doses (Off-Days) of Daily Medication in Patients Stable on Pharmacotherapy for ADHD Receiving Atomoxetine or OROS Methylphenidate: A Parallel Matched Group Clinical Stu... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2009-011611-21 Phase 2 Study of Pemetrexed in Combination with Cisplatin and Cetuximab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck 2012-10-31 bad-data
Listed as ongoing, but also has a completion date and reported results 2009-011739-11 Estudio fase 2 de Pemetrexed y Cisplatino como tratamiento de inducción, seguido de Pemetrexed y Cisplatino en combinación con radioterapia, en pacientes con cáncer de pulmón no microcítico, localment... 2013-07-23 bad-data
Reported results 2009-011837-29 “A Phase 4, 8-week, double-blind, randomized study comparing switching to duloxetine or escitalopram in patients with major depressive disorder and residual apathy in the absence of depressed mood.” 2010-12-17 due-trials
Listed as ongoing, but also has a completion date and reported results 2009-011850-17 A Randomised, Double-Blind, Placebo-Controlled Study to Evaluate the Effect on Unassisted Erectile Function of the Early Use of Tadalafil 5 mg Once a Day and Tadalafil 20 mg On Demand Treatment for 9 ... 2012-11-26 bad-data
Reported results 2009-011883-12 A Phase 2 Study for Transdermal Application of Teriparatide 2011-09-06 due-trials
Listed as ongoing, but also has a completion date 2009-012011-17 Safety and Efficacy of Exenatide Once Weekly versus Liraglutide in subjects with type 2 diabetes and inadequate glycemic control treated with lifestyle modification and oral antidiabetic medications 2011-04-07 bad-data
Ongoing 2009-013420-23 Neurobiological Correlates of Antidepressant Response After Duloxetine Hydrochloride Treatment in Subjects with Major Depressive Disorder not-yet-due
Reported results 2009-013787-39 A Phase 2 Study to Evaluate LY2603618 in Combination with Pemetrexed in Patients with Advanced or Metastatic Non-small Cell Lung Cancer 2015-12-03 due-trials
Listed as ongoing, but also has a completion date and reported results 2009-014176-22 A comparison of prasugrel at the time of percutaneous coronary intervention (PCI) or as pretreatment at the time of diagnosis in patients with NOn-ST-elevation myocardial infarction(NSTEMI): the ACCOA... 2013-02-18 bad-data
Listed as ongoing, but also has a completion date and reported results 2009-014424-29 Estudio de extensión abierto para pacientes con enfermedad de Alzheimer que hayan completado uno de los dos estudios fase 3 doble ciego con Semagacestat (H6L-MC-LFAN o H6L-MC-LFBC). 2011-04-15 bad-data
Listed as ongoing, but also has a completion date and reported results 2009-014591-21 A Randomized Phase 3 Study of Tasisulam Administered as an Intravenous Infusion on Day 1 of a 28-Day Cycle vs. Paclitaxel as Second-Line Treatment in Patients with Metastatic Melanoma. 2011-02-10 bad-data
Listed as ongoing, but also has a completion date and reported results 2009-014605-14 A Phase 4, 8-Week, Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Efficacy of Duloxetine 60 mg Once Daily in Outpatients with Major Depressive Disorder and Associated Painful Physic... 2010-10-26 bad-data
Listed as ongoing, but also has a completion date and reported results 2009-014739-19 A Phase 2 Study of LY2605541 Compared with Insulin Glargine in the Treatment of Type 2 Diabetes Mellitus 2011-01-10 bad-data
Listed as ongoing, but also has a completion date and reported results 2009-014803-30 A Randomized, Open-Label, Parallel-Arm, Noninferiority Comparison of the Effects of Two Doses of LY2189265 and Insulin Glargine on Glycemic Control in Patients with Type 2 Diabetes on Stable Doses of ... 2012-11-23 bad-data
Listed as ongoing, but also has a completion date and reported results 2009-014841-10 Impacto de LY2189265 en comparación con el de metformina en el control glucémico en la Diabetes Mellitus de Tipo 2 Inicial (AWARD-3: Evaluación de la Administración Semanal de LY2189265 en Diabetes – ... 2012-06-19 bad-data
Other 2009-014958-16 A 12-Week, Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of LY2599506 in Patients with Type 2 Diabetes Mellitus Treated with Diet and Exercise, with or without Metformin Estudio de fase ... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2009-016007-39 A 12-Week, Phase 2, Randomized, Double-Blind, Active-Controlled Study of LY2599506 Given as Monotherapy or in Combination with Metformin in Patients with Type 2 Diabetes Mellitus 2010-06-14 bad-data
Listed as ongoing, but also has a completion date and reported results 2009-016245-26 Estudio de Fase 2, de 17 Semanas, Multicéntrico, Aleatorizado y Doble Ciego, Sobre la Eficacia de LY2140023 Combinado con Tratamiento Clínico Habitual Comparado con Placebo Combinado con Tratamiento C... 2012-06-28 bad-data
Listed as ongoing, but also has a completion date 2009-016800-22 A Phase 2 Clinical Study to Evaluate Daily Oral Doses of LY500307 for 24 weeks in Men with Lower Urinary Tract Symptoms (LUTS) and Prostatic Enlargement Secondary to Benign Prostatic Hyperplasia (BPH) 2011-08-30 bad-data
Listed as ongoing, but also has a completion date and reported results 2009-017479-29 A Phase 2 Efficacy and Safety Study of LY2484595 Alone and in Combination with Atorvastatin, Simvastatin, and Rosuvastatin in Patients with Hypercholesterolemia or Low HDL-C 2011-06-28 bad-data
Listed as ongoing, but also has a completion date and reported results 2009-017591-24 A Randomized Phase 2 Study of LY2181308 in Combination with Docetaxel versus Docetaxel in Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer who Were Previously Treated with Fir... 2012-06-29 bad-data
Reported results 2009-017852-28 A Phase 2, Multicenter, Double-Blind, Placebo-Controlled Comparator Study of 2 Doses of LY2140023 versus Placebo in Patients with DSM-IVTR Schizophrenia 2012-05-24 due-trials
Reported results 2009-017853-36 A Long-Term, Open-Label, Multicenter Study of LY2140023 Compared to Atypical Antipsychotic Standard of Care in Patients with DSM-IV-TR Schizophrenia 2012-10-10 due-trials
Reported results 2009-018148-45 An exploratory Phase 2 study of Pemetrexed and Cisplatin as Preoperative chemotherapy in the treatment of Stage IIIAN2 nonsquamous non-Small cell lung cancer 2016-04-05 due-trials
Listed as ongoing, but also has a completion date and reported results 2010-018664-16 A Double-Blind, Randomized, Crossover Trial of CSII Reservoir In-use Comparing Insulin Lispro Formulation to Insulin Aspart in Patients with Type 1 Diabetes Mellitus 2011-12-07 bad-data
Reported results 2010-018759-82 The Effect of Postprandial Hyperglycemia on Arterial Stiffness in Patients with Type 2 Diabetes 2013-02-28 due-trials
Reported results 2010-018948-14 A Dose-Ranging And Efficacy Study of LY2439821 (an Anti-IL-17 Antibody) in Patients With Moderate-To-Severe Psoriasis 2016-08-02 due-trials
Listed as ongoing, but also has a completion date and reported results 2010-019223-55 Comparación del efecto de LY2189265 frente a insulina glargina, administrados en combinación con insulina lispro, para el tratamiento hasta alcanzar el objetivo, en pacientes con diabetes mellitus tip... 2012-09-21 bad-data
Reported results 2010-019581-82 The Effect of LY2189265 on Blood Pressure and Heart Rate, as Assessed by Ambulatory Blood Pressure Monitoring, in Patients with Type 2 Diabetes Mellitus 2012-01-04 due-trials
Ongoing 2010-019724-30 Comparación de insulina lispro premezclada (proporción baja) dos veces al día frente a insulina glargina una vez al día e insulina lispro prandial una vez al día, como estrategias de intensificación d... not-yet-due
Reported results 2010-019758-42 A Phase 2 Randomized Study of LY2541546 Versus Placebo in Postmenopausal Women with Low Bone Mineral Density: An Evaluation of the Dose Response Relationship using Bone Mineral Density 2013-02-22 due-trials
Reported results 2010-020220-22 A Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Effect of Tadalafil Once Daily for 8 Weeks on Prostatic Blood Flow and Perfusion Parameters in Men with Signs and Symptoms of Benig... 2012-09-25 due-trials
Completed, but no date, and reported results 2010-020404-29 A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients with Diabetic Kidney Disease due to Type 1 or Type 2 Diab... bad-data
Completed, reported early 2010-020408-31 A Phase 1/Randomized Phase 2 Study to Evaluate LY2603618 in Combination with Pemetrexed and Cisplatin in Patients with Stage IV Non-small Cell Lung Cancer 2014-09-04 not-yet-due
Listed as ongoing, but also has a completion date and reported results 2010-020604-29 A Phase 3b, randomized, double-blind, placebo-controlled parallel-design study to evaluate the efficacy and safety of tadalafil co-administered with finasteride for 6 months in men with lower urinary ... 2012-05-10 bad-data
Listed as ongoing, but also has a completion date and reported results 2010-020726-18 Estudio Abierto de Seguridad a Largo Plazo de LY2216684 12 a 18 mg Una Vez al Día como Tratamiento Adyuvante para Pacientes con Trastorno Depresivo Mayor con Respuesta Parcial al Tratamiento con un In... 2012-12-27 bad-data
Listed as ongoing, but also has a completion date and reported results 2010-021037-32 A Randomized, Double-Blind, Multicenter Phase 3 Study of Irinotecan, Folinic Acid, and 5-Fluorouracil (FOLFIRI) Plus Ramucirumab or Placebo in Patients With Metastatic Colorectal Carcinoma Progressive... 2016-08-01 bad-data
Listed as ongoing, but also has a completion date and reported results 2010-021069-63 A randomized, placebo, controlled clinical trial to evaluate cardiovascular outcomes after treatment with Exenatide Once Weekly in patients with type 2 diabetes mellitus 2017-04-24 bad-data
Listed as ongoing, but also has a completion date and reported results 2010-021155-11 Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid B Antibody in Patients with Alzheimer's Disease. Monitorización continua de la eficacia y la seguridad de solanezumab, un antic... 2017-02-17 bad-data
Reported results 2010-021214-39 A Randomized, Placebo-controlled, Double-blind Study of LY2216684 Fixed-dose 12 mg and 18 mg Once Daily as Adjunctive Treatment for Patients With Major Depressive Disorder Who Are Partial Responders t... 2013-10-07 due-trials
Reported results 2010-021215-16 A Randomized, Placebo-Controlled, Double-Blind Study of LY2216684 Flexible-Dose 12 mg to 18 mg Once Daily and LY2216684 Fixed-Dose 6 mg Once Daily as Adjunctive Treatment for Patients with Major Depre... 2013-08-13 due-trials
Listed as ongoing, but also has a completion date and reported results 2010-021216-41 A Randomized Placebo-Controlled, Double-Blind Study of LY2216684 Flexible-Dose 12 to 18 mg Once Daily as Adjunctive Treatment for Patients with Major Depressive 2013-04-30 bad-data
Listed as ongoing, but also has a completion date and reported results 2010-021297-11 A Randomized, Double-Blind, Phase 3 Study of Docetaxel and Ramucirumab versus Docetaxel and Placebo in the Treatment of Stage IV Non-Small Cell Lung Cancer Following Disease Progression after One Pri... 2016-08-10 bad-data
Listed as ongoing, but also has a completion date and reported results 2010-021395-28 Effect of Teriparatide on Femoral Neck Fracture Healing 2014-02-04 bad-data
Listed as ongoing, but also has a completion date and reported results 2010-021516-42 Two Approaches to Escalate Lispro Therapy in Patients with Type 2 Diabetes Mellitus Not Achieving Adequate Glycemic Control on Basal Insulin Therapy and Oral Agents Alone 2013-01-14 bad-data
Reported results 2010-022099-29 A Phase 3, Multicenter, Randomized, Double-Blind,Placebo-Controlled Study to Evaluate the Efficacy and Safety of Subcutaneous LY2127399 in Patients with Systemic Lupus Erythematosus (SLE) 2014-12-10 due-trials
Listed as ongoing, but also has a completion date and reported results 2010-022100-42 A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Subcutaneous LY2127399 in Patients with Systemic Lupus Erythematosus (SLE) (ILLUMINATE... 2014-12-10 bad-data
Reported results 2010-022101-18 A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of Subcutaneous LY2127399 in Patients with Systemic Lupus Erythematosus (SLE) (ILLUMINATE-X) 2015-01-12 due-trials
Completed, reported early 2010-022160-13 Phase 1b/2a Study Combining LY2157299 with Standard Temozolomide-based Radiochemotherapy in Patients with Newly Diagnosed Malignant Glioma 2016-11-23 not-yet-due
Reported results 2010-022205-17 A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of LY2127399 in Patients with Moderate to Severe Rheumatoid Arthritis (RA) who had an Ina... 2014-01-21 due-trials
Reported results 2010-022206-40 A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients with Rheumatoid Arthritis (RA) with or without Background Diseas... 2013-07-23 due-trials
Reported results 2010-022207-22 A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of LY2127399 in Patients with Moderate to Severe Rheumatoid Arthritis (RA) who had an Ina... 2014-01-06 due-trials
Listed as ongoing, but also has a completion date and reported results 2010-022208-36 A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of LY2127399 in Patients with Rheumatoid Arthritis (RA) 2014-02-25 bad-data
Ongoing 2010-022338-10 Phase 2 Study of LY2157299 in Patients with Hepatocellular Carcinoma not-yet-due
Listed as ongoing, but also has a completion date and reported results 2010-022504-42 A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Parallel-Group, Phase 2b Study of LY3009104 in Patients with Active Rheumatoid Arthritis on background Methotrexate Therapy 2014-03-31 bad-data
Ongoing 2010-022674-14 Estudio en fase 2, abierto, multicéntrico y aleatorizado para evaluar la seguridad y la eficacia de cisplatino y pemetrexed con o sin cixutumumab como tratamiento de primera línea en pacientes con car... not-yet-due
Reported results 2010-023231-42 A randomized, double-blind, placebo-controlled, Phase 2b study of LY2409021 in patients with type 2 diabetes mellitus 2012-03-19 due-trials
Listed as ongoing, but also has a completion date and reported results 2010-023550-36 A Phase 3, Multicenter, Double-Blind Comparison of LY2140023 and Aripiprazole in Patients with DSM-IV-TR Schizophrenia Followed by Open-Label Treatment with LY2140023 2012-08-29 bad-data
Ongoing 2010-023799-21 The Effect of Dulaglutide on Major Cardiovascular Events in Patients with Type 2 Diabetes: Researching Cardiovascular Events with a Weekly INcretin in Diabetes (REWIND) not-yet-due
Reported results 2010-024014-60 An Open-label, Multicenter, Randomized Phase 2 Study Evaluating the Safety and Efficacy of Cisplatin and Pemetrexed With or Without Cixutumumab as First Line Therapy in Patients with Advanced Nonsquam... 2016-06-10 due-trials
Reported results 2010-024320-23 A Proof-of-Concept Study of the Effects of LY2828360 in the Treatment of Patients with Osteoarthritic Knee Pain 2011-09-13 due-trials
Listed as ongoing, but also has a completion date and reported results 2010-024632-42 LY2216684 compared to Placebo as Adjunctive Therapy to SSRI in the Prevention of Symptom Re-emergence in Major Depressive Disorder 2013-11-14 bad-data
Reported results 2011-000211-64 A Phase 1b/2 Study with Gemcitabine and LY2157299 for Patients with Metastatic Cancer (Phase 1b) and Advanced or Metastatic Unresectable Pancreatic Cancer (Phase 2) 2016-12-26 due-trials
Listed as ongoing, but also has a completion date and reported results 2011-000426-29 A Phase 2 Randomized Study to Investigate the Efficacy and Safety of LY2495655 Versus Placebo in Older Patients Undergoing Elective Total Hip Arthroplasty (eTHA) 2014-02-19 bad-data
Listed as ongoing, but also has a completion date and reported results 2011-000828-15 A Prospective, Randomized, Double-Blind Comparison 2012-09-18 bad-data
Reported results 2011-000829-73 A Prospective, Randomized, Open-Label Comparison of a 2013-03-25 due-trials
Listed as ongoing, but also has a completion date and reported results 2011-000841-19 Home Delivery of Pemetrexed as Maintenance Treatment in Patients Who Have Not Progressed after Induction Therapy for Advanced Nonsquamous Nonsmall Cell Lung Cancer: A Feasibility Study 2013-09-23 bad-data
Listed as ongoing, but also has a completion date and reported results 2011-000842-39 A Comparison of LY2605541 versus Insulin Glargine as Basal Insulin Treatment in Combination with Oral Anti-Hyperglycemia Medications in Insulin-Naïve Patients with Type 2 Diabetes Mellitus: A Doub... 2014-01-24 bad-data
Ongoing 2011-001012-56 A Phase 2 Study of LY2784544 in Patients with Myeloproliferative Neoplasms not-yet-due
Listed as ongoing, but also has a completion date and reported results 2011-001116-65 Second study of the Effect of Teriparatide on Femoral Neck Fracture Healing 2013-12-04 bad-data
Listed as ongoing, but also has a completion date and reported results 2011-001253-82 Protocol I2R-MC-BIAO 2014-02-03 bad-data
Listed as ongoing, but also has a completion date and reported results 2011-001254-29 Protocol I2R-MC-BIAM 2013-08-13 bad-data
Listed as ongoing, but also has a completion date and reported results 2011-001261-40 Protocol I2R-MC-BIAN (a) 2014-06-06 bad-data
Ongoing 2011-001873-24 A multiple ascending dose study of Tadalafil to assess the pharmacokinetics and safety in a pediatric population with Pulmonary Arterial Hypertension not-yet-due
Reported results 2011-002292-41 A Phase 3, Short-Term, Multicenter, Placebo-Controlled, Randomized Withdrawal Study of LY2140023 Monohydrate in Patients with DSM-IV-TR Schizophrenia 2012-09-18 due-trials
Listed as ongoing, but also has a completion date 2011-002325-22 A Multicenter, Randomized, Double-Blind, Active and Placebo-Controlled 16-Week Study Followed by Long-Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in Patients with Active Ankylosin... 2013-12-15 bad-data
Listed as ongoing, but also has a completion date 2011-002326-49 A Multicenter, Randomized, Double-Blind, Active and Placebo-Controlled 24-Week Study Followed by Long-Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in Biologic Disease-Modifying Ant... 2017-09-22 bad-data
Ongoing 2011-002328-42 Protocol I1F-MC-RHBE not-yet-due
Ongoing 2011-002970-22 A Multicenter Study with a Randomized, Double-Blind, Placebo-Controlled Induction Dosing Period Followed by a Randomized Maintenance Dosing Period and a Long-Term Extension Period to Evaluate the Effi... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2011-003810-18 A Randomized, Open-Label, Parallel-Arm Study Comparing the Effect of Once-Weekly Dulaglutide with Once-Daily Liraglutide in Patients with Type 2 Diabetes (AWARD-6: Assessment of Weekly AdministRation ... 2013-11-25 bad-data
Ongoing 2011-003822-29 A Randomized Phase 2 Placebo-Controlled Study of LY2495655 in Patients with Advanced or Metastatic Pancreatic Cancer Receiving Chemotherapy not-yet-due
Reported results 2011-004327-13 Long-Term Open-Label Safety Study of LY2140023 in Patients with Schizophrenia 2012-10-19 due-trials
Ongoing 2011-004350-26 A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Efficacy and Safety of LY2439821 to Etanercept and Placebo in Patients with Moderate-to-Severe Plaque Psoriasis not-yet-due
Ongoing 2011-004368-31 A 12-Week Multicenter, Randomized, Double-Blind, Placebo Controlled Study Comparing the Efficacy and Safety of LY2439821 to Etanercept and Placebo in Patients with Moderate to Severe Plaque Psoriasis ... not-yet-due
Ongoing 2011-004418-40 A Phase 2 Study of LY2157299 Monohydrate Monotherapy or LY2157299 Monohydrate plus Lomustine Therapy compared to Lomustine Monotherapy in Patients with Recurrent Glioblastoma not-yet-due
Listed as ongoing, but also has a completion date and reported results 2011-005103-32 A Multicenter, Randomized, Double-Blind, Placebo Controlled Phase 2/3 Study of LY2127399 in Combination with Bortezomib and Dexamethasone in Patients with Previously Treated Multiple Myeloma 2014-10-28 bad-data
Listed as ongoing, but also has a completion date 2011-005197-40 A Randomized, Double-Blind, Placebo-Controlled Phase 1b/2 Study of LY2228820, a p38MAPK Inhibitor, plus Gemcitabine and Carboplatin versus Gemcitabine and Carboplatin for Women with Platinum-Sensitive... 2018-05-11 bad-data
Reported results 2011-005217-37 Assessment of Safety, Tolerability, and Pharmacodynamic Effects of LY2886721 in Patients with Mild Cognitive Impairment Due to Alzheimer’s Disease or Mild Alzheimer's Disease 2013-06-13 due-trials
Listed as ongoing, but also has a completion date and reported results 2011-005866-39 A Comparison of LY2605541 versus Insulin Glargine Alone or in Combination with Pre study Oral Antihyperglycemic Medications in Patients with Type 2 Diabetes Mellitus Previously Treated with Basal Insu... 2013-12-17 bad-data
Reported results 2011-006062-40 A Phase 2 Randomized Study to Investigate the Efficacy and Safety of LY2495655 Versus Placebo in Older Patients Who Have Fallen Recently and Have Muscle Weakness 2013-12-13 due-trials
Listed as ongoing, but also has a completion date and reported results 2012-000061-21 Protocol I1V-MC-EIAN Assessment of Clinical Effects of Cholesteryl Ester Transfer Protein Inhibition with Evacetrapib in Patients at a High-Risk for Vascular Outcomes - the ACCELERATE Study 2016-07-19 bad-data
Reported results 2012-000123-41 Teriparatide and Risedronate in the Treatment of Patients with Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures 2016-07-14 due-trials
Reported results 2012-000773-23 Study of the Safety and Efficacy of LY2623091 in Chronic Kidney Disease Patients 2013-03-20 due-trials
Reported results 2012-000829-44 A Randomized, Open-Label, Parallel-Arm Study Comparing the Effect of Once-Weekly Dulaglutide with Insulin Glargine on Glycemic Control in Patients with Type 2 Diabetes and Moderate or Severe Chronic K... 2016-12-20 due-trials
Reported results 2012-001618-40 Pharmacokinetic Evaluations of Tabalumab Following Subcutaneous Administration by Prefilled syringe or Auto-Injector in Patients with Rheumatoid Arthritis Who Have Had an Inadequate Response to Methot... 2013-02-07 due-trials
Listed as ongoing, but also has a completion date and reported results 2012-002322-73 A Randomized, Double-Blind, Placebo- and Active Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib in Patients with Moderately to Severely Active Rheumatoid Arthritis Who Have... 2015-09-29 bad-data
Listed as ongoing, but also has a completion date and reported results 2012-002323-15 A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study Evaluating the Efficacy and Safety of Baricitinib (LY3009104) in Patients with Moderately to Severely Active Rheumatoid Arthritis Who Have... 2014-11-04 bad-data
Listed as ongoing, but also has a completion date and reported results 2012-002324-32 A Randomized, Double-Blind, Active-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients with Moderately to Severely Active Rheumatoid Arthritis Who Have... 2015-10-22 bad-data
Listed as ongoing, but also has a completion date and reported results 2012-002339-27 A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients with Inadequate Response to Conventional Disease-Modifying Anti... 2015-01-07 bad-data
Ongoing 2012-002354-23 A Double-Blind Efficacy and Safety Study of the Phosphodiesterase Type 5 Inhibitor Tadalafil in Pediatric Patients with Pulmonary Arterial Hypertension not-yet-due
Reported results 2012-002911-24 Protocol H9X-MC-GBDG 2014-12-02 due-trials
Listed as ongoing, but also has a completion date 2012-003174-83 A Phase 1b/2 Double-Blind Randomized Trial of the 2014-09-09 bad-data
Reported results 2012-003201-96 A Single-Arm, Multicenter, Open-Label, Phase 2 Study of Gemcitabine-Cisplatin Chemotherapy Plus Necitumumab (IMC-11F8) in the First-Line Treatment of Patients With Stage IV Squamous Non-Small Cell Lun... 2015-12-03 due-trials
Completed, reported early 2012-003214-13 A Randomized, Multicenter, Open-Label, Phase 2 Study of 2017-07-14 not-yet-due
Ongoing 2012-003686-17 A Phase 3, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients with Rheumatoid Arthritis not-yet-due
Listed as ongoing, but also has a completion date and reported results 2012-003837-41 A Phase 3, Double-Blind, Randomized, Efficacy and Safety Comparison of Prasugrel and Placebo in Pediatric Patients with Sickle Cell Disease 2015-09-16 bad-data
Reported results 2012-003941-13 A Comparison of LY2605541 versus Human Insulin NPH as Basal Insulin Treatment in Insulin-Naïve Patients with Type 2 Diabetes Mellitus not Adequately Controlled with 2 or more Oral Antihyperglycemic Me... 2014-05-28 due-trials
Listed as ongoing, but also has a completion date and reported results 2012-004229-25 A Randomized, Double-Blind Trial Comparing the Effect of Dulaglutide 1.5 mg with Placebo on Glycemic Control in Patients with Type 2 Diabetes on Basal Insulin Glargine 2015-10-15 bad-data
Listed as ongoing, but also has a completion date and reported results 2012-004496-40 Study of the Safety and Efficacy of LY3016859 after Multiple Intravenous Dosing in Diabetic Nephropathy Patients 2015-08-15 bad-data
Reported results 2012-004866-16 A Randomized, Double-Blind, Placebo-Controlled Parallel Study with an Open-Label Extension to Assess the Impact of Testosterone Solution on Total Testosterone, Sex Drive and Energy in Hypogonadal Men. 2015-06-30 due-trials
Reported results 2012-005174-56 A Comparison of Pharmacodynamics When Receiving a Double Dose of Insulin Peglispro or Insulin Glargine in Patients with Type 2 Diabetes Mellitus: A Double-Blind, Crossover Design Study: The IMAGINE 8... 2015-07-10 due-trials
Ongoing 2012-005476-33 A Randomized, Controlled Phase 2 Study Evaluating LY2875358 plus Erlotinib versus Erlotinib as First-Line Treatment in Metastatic Non–Small Cell Lung Cancer Patients with Activating EGFR Mutations Who... not-yet-due
Reported results 2012-005477-31 A Randomized, Open-Label Phase 2 Study Evaluating LY2875358 Plus Erlotinib and LY2875358 Monotherapy in MET Diagnostic Positive NSCLC Patients with Acquired Resistance to Erlotinib 2016-05-31 due-trials
Reported results 2013-000622-55 A Phase 2 Efficacy and Safety Dose-Ranging Study of LY3015014 in Patients with Primary Hypercholesterolemia 2014-06-06 due-trials
Listed as ongoing, but also has a completion date and reported results 2013-001119-54 Effect of Passive Immunization on the Progression of Mild Alzheimer’s Disease: Solanezumab (LY2062430) versus Placebo 2017-02-17 bad-data
Listed as ongoing, but also has a completion date and reported results 2013-001194-25 A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial of Tadalafil for Duchenne Muscular Dystrophy 2016-01-29 bad-data
Reported results 2013-001473-24 An Individualized treatMent aPproach for oldER patIents: A randomized, controlled stUdy in type 2 diabetes Mellitus 2015-10-14 due-trials
Completed, reported early 2013-002935-12 Effect of Evacetrapib on the Pharmacokinetics of Pravastatin in Healthy Japanese and Non-Japanese Subjects 2014-01-20 not-yet-due
Listed as ongoing, but also has a completion date 2013-003235-30 Phase 2/3 Study of Monotherapy LY2157299 Monohydrate in Very Low-, Low-, and Intermediate-Risk Patients with Myelodysplastic Syndromes 2017-09-24 bad-data
Listed as ongoing, but also has a completion date 2013-003552-21 Comparison of the Oxyntomodulin Analog, LY2944876, to Once-Weekly Exenatide and to Placebo in Patients with Type 2 Diabetes. 2015-10-23 bad-data
Reported results 2013-003834-33 Protocol I1R-MC-GLDI 2015-01-20 due-trials
Reported results 2013-004275-12 A Phase 2, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of LY2409021 Compared to Sitagliptin in Subjects with Type 2 Diabetes Mellitus 2015-09-28 due-trials
Ongoing 2013-004662-33 A Randomized Phase 3 Study of LY2835219 plus Best Supportive Care versus Erlotinib plus Best Supportive Care in Patients with Stage IV NSCLC with a Detectable KRAS Mutation Who Have Progressed After P... not-yet-due
Ongoing 2013-004728-13 A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of Fulvestrant with or without abemaciclib, a CDK4/6 Inhibitor, for Women with Hormone Receptor Positive, HER2 Negative Locally Advanced o... not-yet-due
Ongoing 2013-005548-27 A Phase 2 Study of LY2835219 for Patients with Previously Treated Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer not-yet-due
Ongoing 2014-001502-18 A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of Nonsteroidal Aromatase Inhibitors (Anastrozole or Letrozole) Plus LY2835219, a CDK4/6 Inhibitor, or Placebo in Postmenopausal Women Wit... not-yet-due
Listed as ongoing, but also has a completion date 2014-002240-40 A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Capecitabine and Cisplatin With or Without Ramucirumab as First-line Therapy in Patients With Metastatic Gastric or Gastroesophageal Jun... 2017-11-06 bad-data
Ongoing 2014-002601-38 A 24-Month, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Efficacy, Safety, Tolerability, Biomarker and Pharmacokinetics Study of AZD3293 in Early Alzheimer’s Disease (The... not-yet-due
Ongoing 2014-003655-66 A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Ramucirumab plus Docetaxel versus Placebo plus Docetaxel in Patients with Locally Advanced or Unresectable or Metastatic Urothelial Car... not-yet-due
Ongoing 2014-003791-23 Protocol I4T-MC-JVDB Randomized Phase 2 Trial Evaluating Pharmacokinetics and Safety of Four Ramucirumab Dosing Regimens in Second Line Gastric or Gastroesophageal Junction Adenocarcinoma not-yet-due
Ongoing 2014-004010-28 A Phase 2 Study of Abemaciclib in Patients with Brain Metastases Secondary to Hormone Receptor Positive Breast Cancer, Non-small Cell Lung Cancer, or Melanoma not-yet-due
Ongoing 2014-004824-22 A Multicenter, Randomized, Double-Blind Study of Erlotinib in Combination with Ramucirumab or Placebo in Previously Untreated Patients with EGFR Mutation-Positive Metastatic Non-Small Cell Lung Cancer not-yet-due
Ongoing 2014-004832-20 A Randomized Phase 2 Study of Abemaciclib (LY2835219) versus Docetaxel in Patients with Stage IV Squamous Non-Small Cell Lung Cancer Previously Treated with Platinum-based Chemotherapy not-yet-due
Completed, report not yet due 2014-005024-10 A Phase 1b/Randomized Phase 2 Study to Evaluate LY3039478 in Combination with 2018-01-15 not-yet-due
Ongoing 2014-005042-21 A Single-Arm, Multicenter, Phase 1b Study with an Expansion Cohort to Evaluate Safety and Efficacy of Necitumumab in Combination with Abemaciclib in Treatment of Patients with Stage IV Non-Small Cell ... not-yet-due
Listed as ongoing, but also has a completion date 2014-005067-32 Protocol I4T-MC-JVCZ 2018-04-03 bad-data
Ongoing 2014-005068-13 Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of Ramucirumab and Best Supportive Care (BSC) Versus Placebo and BSC as Second-Line Treatment in Patients With Hepatocellular Carcinoma and ... not-yet-due
Ongoing 2014-005429-11 A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 with a Long-Term Open-Label Extension in Patients with Chronic Cluster Headache not-yet-due
Completed, report not yet due 2014-005486-75 neoMONARCH: A Phase 2 Neoadjuvant Trial Comparing the Biological Effects of 2 Weeks of Abemaciclib (LY2835219) in Combination with Anastrozole to those of Abemaciclib Monotherapy and Anastrozole Monot... 2018-02-12 not-yet-due
Ongoing 2015-000134-30 A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial of Doxorubicin plus Olaratumab versus Doxorubicin plus Placebo in Patients with Advanced or Metastatic Soft Tissue Sarcoma not-yet-due
Listed as ongoing, but also has a completion date 2015-000149-22 A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients with Episodic Cluster Headache 2018-06-04 bad-data
Listed as ongoing, but also has a completion date 2015-000190-12 A Multicenter, Randomized, Double-Blind Study Comparing the Efficacy and Safety of Ixekizumab Dosing Regimens in Patients with Moderate-to-Severe Plaque Psoriasis 2017-08-03 bad-data
Completed, report not yet due 2015-000892-28 A 52-Week Multicenter, Randomized, Blinded, Parallel Group Study Comparing the Efficacy and Safety of Ixekizumab to Ustekinumab in Patients with Moderate to Severe Plaque Psoriasis 2017-10-05 not-yet-due
Ongoing 2015-001316-34 A Phase 1b (Open-Label) / Phase 2 (Randomized, not-yet-due
Ongoing 2015-001882-17 A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients with Episodic Migraine - the EVOLVE-2 Study not-yet-due
Ongoing 2015-001883-21 A Phase 3, Randomized, Double-Blind, Placebo-Controlled not-yet-due
Ongoing 2015-001884-38 A Phase 3, Long-Term, Open-Label Safety Study of LY2951742 in Patients with Migraine. not-yet-due
Ongoing 2015-002093-20 A Phase 1b/2 Dose Escalation and Cohort Expansion Study of the Safety, Tolerability and Efficacy of a Novel Transforming Growth Factor-beta Receptor I Kinase Inhibitor (Galunisertib) Administered in C... not-yet-due
Reported results 2015-002095-24 Protocol H9X-MC-GBGE(a) A Randomized, Parallel-Arm, Double-Blind Study of Efficacy and Safety of Dulaglutide When Added to SGLT2 Inhibitors in Patients with Type 2 Diabetes Mellitus (AWARD-10: Assess... 2017-02-03 due-trials
Ongoing 2015-002433-22 A Phase 3, Multicenter Study with a 36-Week Open-Label Period Followed by a Randomized Double-Blind Withdrawal Period from Week 36 to Week 104 to Evaluate the Long Term Efficacy and Safety of Ixekizum... not-yet-due
Completed, report not yet due 2015-002628-14 A Multicenter, Randomized, Double-Blind Study Comparing the Efficacy and Safety of Ixekizumab Versus Placebo in Patients with Moderate-to-Severe Genital Psoriasis 2018-02-21 not-yet-due
Completed, report not yet due 2015-002649-69 A 24-Week Multicenter, Randomized, Open-Label, Parallel Group Study Comparing the Efficacy and Safety of Ixekizumab to Fumaric Acid Esters and Methotrexate in Patients with Moderate-to-Severe Plaque P... 2017-11-14 not-yet-due
Ongoing 2015-003123-57 A Phase 2, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Study of LY3074828 in Subjects with Moderate to Severe Ulcerative Colitis not-yet-due
Listed as ongoing, but also has a completion date 2015-003289-97 A Randomized, Double-Blind, Placebo-Controlled, 2-Part Phase 2 Study to Evaluate the Safety and Efficacy of LY3337641 in Adult Subjects with Rheumatoid Arthritis: The RAjuvenate Study 2018-02-14 bad-data
Ongoing 2015-003400-24 monarcHER: A Phase 2, Randomized, Multicenter, 3-Arm, Open-Label Study to Compare the Efficacy of Abemaciclib plus Trastuzumab with or without Fulvestrant to Standard-of-Care Chemotherapy of Physician... not-yet-due
Ongoing 2015-003932-11 A Multicenter, Randomized, Double-Blind, Active and Placebo-Controlled 16 Week Study Followed by Long Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in bDMARD-Naive Patients with Rad... not-yet-due
Ongoing 2015-003937-84 A Multicenter, Randomized, Double-Blind, Placebo-Controlled 16 Week Study Followed by Long Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in TNFi-Experienced Patients with Radiograph... not-yet-due
Ongoing 2015-003938-27 A 52 Week Multicenter, Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ixekizumab (LY2439821) in bDMARD Naive Patients with Nonradiographic Axial Spondyloarth... not-yet-due
Completed, report not yet due 2015-004404-35 A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Study of Baricitinib in Patients with Systemic Lupus Erythematosus (SLE) 2017-11-09 not-yet-due
Ongoing 2015-004699-31 Randomized, Double-Blind, Phase 2 Study of Ramucirumab or Merestinib or Placebo plus Cisplatin and Gemcitabine as First-Line Treatment in Patients with Advanced or Metastatic Biliary Tract Cancer not-yet-due
Ongoing 2015-005069-21 A Phase 2 Study of LY2606368 in Patients with Extensive Stage Disease Small Cell Lung Cancer not-yet-due
Ongoing 2015-005156-94 Protocol I3Y-MC-JPCE not-yet-due
Ongoing 2015-005234-21 A Phase 3b Multicenter, Single-Arm, Open-Label Safety Study of LY2951742 (galcanezumab) in Patients with Episodic or Chronic Cluster Headache not-yet-due
Ongoing 2015-005356-99 A Prospective, Randomized, Double-Blind Comparison of LY900014 to Insulin Lispro with an Open-Label Postprandial LY900014 Treatment Group, in Combination with Insulin Glargine or Insulin Degludec, in ... not-yet-due
Ongoing 2015-005357-12 Protocol I8B-MC-ITRN not-yet-due
Listed as ongoing, but also has a completion date 2015-005625-39 A Randomized, Double-Blind, Placebo-Controlled and Delayed-Start Study of LY3314814 in Mild Alzheimer’s Disease Dementia (The DAYBREAK Study) 2018-12-31 bad-data
Ongoing 2015-005674-37 An Open-label, LonG-term, Safety Study of LAsmiDItan (100 mg and 200 mg) in the Acute Treatment Of MigRaine (GLADIATOR) not-yet-due
No trial status on register 2015-005721-39 A Phase 1, Open-Label, Dose-Escalation Study of Olaratumab as a Single Agent and in Combination with Doxorubicin, Vincristine/Irinotecan, or High-dose Ifosfamide in Pediatric Patients with Relapsed or... bad-data
Listed as ongoing, but also has a completion date and reported results 2016-000108-27 A 24-Month, Phase 3, Multicenter, Placebo-Controlled Study 2017-05-08 bad-data
Ongoing 2016-000288-18 A Randomized, Open-Label, Phase 2 Study of Abemaciclib plus Tamoxifen or Abemaciclib Alone, in Women with Previously Treated Hormone Receptor-Positive, HER2-Negative, Metastatic Breast Cancer not-yet-due
Other 2016-000361-22 A Randomized, Double-Blind Study with an Open-Label Extension Comparing the Effect of Once-Weekly Dulaglutide with Placebo in Pediatric Patients with Type 2 Diabetes Mellitus not-yet-due
Ongoing 2016-001098-34 Protocol I6T-MC-AMAF not-yet-due
Ongoing 2016-001099-31 A Phase 1b (Open-Label) / Phase 2 (Randomized, Double-Blinded) Study Evaluating Nab-Paclitaxel and Gemcitabine With or Without Olaratumab in the Treatment of First-Line Metastatic Pancreatic Cancer not-yet-due
Ongoing 2016-001317-25 A Single-Arm, Phase 2 Study of Ramucirumab in Combination with Weekly Docetaxel in Patients with Stage IV Non-Small Cell Lung Cancer Following Disease Progression after Prior Platinum-based Chemothera... not-yet-due
No trial status on register 2016-001502-42 Effect of Early Growth Hormone Treatment on Long-term Growth and Skeletal Maturation in Girls With Turner Syndrome bad-data
Completed, but no date 2016-002041-31 A Single-Arm, Multicenter, Phase 2 Study of Gemcitabine-Carboplatin Chemotherapy Plus Necitumumab in the First-Line Treatment of Patients with Locally Advanced or Metastatic Squamous Non-Small Cell Lu... bad-data
Ongoing 2016-002071-96 A Single-Arm, Multicenter, Open-Label, Phase 2 Study of nab®-Paclitaxel (Abraxane®) and Carboplatin Chemotherapy plus Necitumumab (LY3012211) in the First-Line Treatment of Patients with Stage IV Squa... not-yet-due
Ongoing 2016-002204-84 A Phase 2, Multicenter, Randomized, Parallel-Arm, Placebo- Controlled Study of LY3074828 in Subjects with Active Crohn’s Disease (SERENITY) not-yet-due
Ongoing 2016-002218-36 An Adaptive, Open-Label, Randomized Phase 2 Study of Abemaciclib as a Monotherapy and in Combination with Other Agents Versus Choice of Standard of Care (Gemcitabine or Capecitabine) in Patients with ... not-yet-due
Completed, reported early 2016-002494-34 A Phase 2, Double-Blind, Placebo-Controlled, 18-Week Trial of Investigational Dulaglutide Doses versus Placebo in Patients with Type 2 Diabetes on Metformin Monotherapy 2017-08-14 not-yet-due
Ongoing 2016-002634-69 Protocol I1F-MC-RHBY not-yet-due
Other 2016-003331-38 Multicenter, Double-Blind, Randomized, Active- and Placebo Controlled Study to Evaluate Safety, Tolerability, and Efficacy of Ixekizumab in Patients from 6 to Less than 18 Years of Age with Moderate-t... not-yet-due
Listed as ongoing, but also has a completion date 2016-003440-36 A Randomized, Double-Blind, Delayed-Start Study of LY3314814 (AZD3293) in Early Alzheimer’s Disease Dementia (Extension of Study AZES, The AMARANTH Study) 2018-12-31 bad-data
Completed, report not yet due 2016-004179-33 A Phase 2 Study of Once-Weekly LY3298176 Compared with Placebo and Dulaglutide in Patients with Type 2 Diabetes Mellitus 2018-03-28 not-yet-due
Ongoing 2016-004362-26 A Randomized, Open-Label, Phase 3 Study of Abemaciclib Combined with Standard Adjuvant Endocrine Therapy versus Standard Adjuvant Endocrine Therapy Alone in Patients with High Risk, Node Positive, Ear... not-yet-due
Ongoing 2016-004585-25 A 52-Week Multicenter, Randomized, Open-Label, Parallel-Group Study Evaluating the Efficacy and Safety of Ixekizumab versus Adalimumab in Patients with Psoriatic Arthritis Who Are Biologic Disease-Mod... not-yet-due
Ongoing 2016-004675-52 A Multicenter, Randomized, Double-Blind, Placebo-Controlled, 24 Week Study Followed by Long-Term Treatment for Evaluation of Efficacy and Safety of Baricitinib in Patients with Active Psoriatic Arthri... not-yet-due
No trial status on register 2017-000095-28 A Phase II Study of Pemetrexed in Children with bad-data
No trial status on register 2017-000211-16 F1J-MC-HMFN (a) An Open-Label Study of Tolerability, Safety, and Pharmacokinetics of Duloxetine in the Treatment of Children and Adolescents With Major Depressive Disorder bad-data
Ongoing 2017-000870-12 A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients with Moderate to Severe Atopic Dermatitis not-yet-due
Ongoing 2017-000871-10 A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Patients with Moderate to Severe Atopic Dermatitis not-yet-due
Ongoing 2017-000873-35 Protocol I4V-MC-JAHN: A Phase 3 Multicenter, Double-Blind Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Adult Patients with Atopic Dermatitis not-yet-due
No trial status on register 2017-001162-21 An Open-Label, Randomized, Crossover Trial of CSII Reservoir In-use Comparing Insulin Lispro Formulation to Insulin Aspart in Patients with Type 1 Diabetes Mellitus bad-data
No trial status on register 2017-001243-12 An Open-Label, Dose-Ranging Study of Prasugrel in Pediatric Patients With Sickle Cell Disease bad-data
No trial status on register 2017-001598-18 A Double-Blind, Efficacy and Safety Study of Duloxetine Versus Placebo in the Treatment of Children and Adolescents With Major Depressive Disorder bad-data
No trial status on register 2017-001599-46 A Double-Blind, Efficacy and Safety Study of Duloxetine Versus Placebo in the Treatment of Children and Adolescents With Generalized Anxiety Disorder bad-data
Ongoing 2017-002374-39 Protocol I8B-MC-ITSI A Prospective, Randomized, Double-Blind, Crossover Comparison Evaluating Compatibility and Safety of LY900014 and Insulin Lispro with an External Continuous Subcutaneous Insulin I... not-yet-due
No trial status on register 2017-003220-78 A Study to Evaluate the Pharmacokinetics and Glucodynamics of LY900014 Compared to Humalog in Children, Adolescents, and Adults with Type 1 Diabetes Mellitus bad-data
Ongoing 2017-003229-14 A Phase 3, Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Induction Study of Mirikizumab in Conventional-Failed and Biologic-Failed Patients with Moderately to Severely Active Ulc... not-yet-due
Ongoing 2017-003238-96 A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL-ARM, PLACEBO-CONTROLLED MAINTENANCE STUDY OF MIRIKIZUMAB IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS (LUCENT 2) not-yet-due
Ongoing 2017-003286-10 A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Efficacy and Safety of Mirikizumab to Secukinumab and Placebo in Patients with Moderate-to-Severe Plaque Psoriasis not-yet-due
Ongoing 2017-003298-32 A Multicenter Study with a Randomized, Double-Blind, Placebo-Controlled Induction Dosing Period Followed by a Randomized Withdrawal Maintenance Dosing Period to Evaluate the Efficacy and Safety of Mir... not-yet-due
Ongoing 2017-003490-33 A Randomized, Double-Blind, Parallel Arm Study of the Efficacy and Safety of Investigational Dulaglutide Doses not-yet-due
Ongoing 2017-004009-42 A Phase 2 Study of Prexasertib in Platinum-Resistant or Refractory Recurrent Ovarian Cancer not-yet-due
Ongoing 2017-004092-31 I6T-MC-AMAP not-yet-due
Ongoing 2017-004574-34 A Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Safety and Efficacy of Baricitinib in Combination with Topical Corticosteroids in Adult Patients with Moderate... not-yet-due
Ongoing 2018-000600-42 A Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Adults with Treatment-Resistant Migraine - The CONQUER Study not-yet-due